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A B S T R A C T
All the people are exposed to solar ultraviolet radiation. Exposure to sun with living in an oxygen-rich atmosphere
causes unwanted photodemage. Sunburned skin is a leading risk factor for melanoma and non-melanoma cancers. UV
exposure causes immunosuppression via multiple mechanisms in the skin. In this review the main topic is to mention
new or alternative ways of photoprotection. Sunscreens are commonly used as protection against sun damage. They re-
duce the penetration of damaging solar UV wavelengths in skin by reflecting or absorbing them. Sunscreens are very
valuable, but they have limitations. They have to be used properly to gain the full effect (application a little while before
UV exposure, at frequent time points and in adequate amounts). Also, they have the problem of photoinactivation, which
is the degeneration of the UV-filter due to exposure to UV rays resulting in the loss of absorbing capacity. Products with
immune protection factor contain DNA-repair enzymes and antioxidants that may reduce mutations and enable the im-
mune system to combat photodamage. The use of antioxidants and polyphenols may exert an anti-aging effect by prevent-
ing and even reversing sun damage. Adequate photprotection is essential to control photocarcinogenesis and photoaging.
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The sun emits visible light, infrared radiation, which
is not considered harmful to humans, and UV rays. Less
than 5% of the sunlight that reaches the earth’s surface
is ultraviolet radiation. All the people are exposed to so-
lar ultraviolet radiation. Exposure to sun with living in
an oxygen-rich atmosphere causes unwanted photode-
mage. Exposure of the skin to ultraviolet radiation, mai-
nly its UVB and UVA components, results in erythema,
edema, hyperpigmentation, sunburn cells, immunosu-
presion, photoaging and skin cancer.
Having a suntan has long been synonymous with
beauty, good health and dynamism in our culture. Also,
an increasing number of people are exposed to artificial
source of ultraviolet radiation used in industries, com-
mercial settings and leisure activities. Sunburned skin is
a leading risk factor for melanoma and non-melanoma
cancers.
Four processes control the penetration of UV rays
into the skin.
Reflexion is diffuse and occurs at the level of cornified
layer.
Diffusion is important for the cornified layer and for
melanin that mainly diffuses short wavelengths.
Absorption occurs in the cornified layer where 70% of
UVB is absorbs through the polar amino acid of keratin
and urocanic acid, while melanin and carotenoids absorb
UV rays and visible light.
The fraction of the beam escaped the three latter pro-
cesses corresponds to transmission and penetrate the
skin1.
When skin is exposed to sunlight, UV rays are ab-
sorbed by skin molecules that then can generate harmful
compounds, called reactive oxygen species or ROS, which
are highly reactive molecules that can cause oxidative
damage. ROS can react with cellular components like cell
walls, lipid membranes, mitochondria and DNA, leading
to skin damage and increasing visible signs of aging2.
Mechanisms of UV rays exposure induced
skin damage
Sun-exposed skin areas are characterized clinically by
fine and coarse wrinkling, roughness, dryness, laxity,
teleangiectasia, loss of tensile strength and pigmentary
changes. There is also an increase in development of be-
nign and malignant neoplasms on photoaged skin. It is a
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cumulative process and depends primarily on the degree
of sun exposure and skin pigment. The epidermis and
dermis are both affected by UVB, but the dermis is also
affected to a significant extent by UVA. It has long been
thought that the majority of human photolesions due to
UVB rays, now it is believed that UVA play a substantial
role in photoaging. Because UVB is essentially com-
pletely absorbed in the epidermis, it has been important
to understand that photoaging changes can be produced
by UVA alone. Indeed, these changes have been produced
in photoprotected skin by a small number of low-dose ex-
posures of UVA radiation2,3.
When the skin is chronic exposure to UV rays, the epi-
dermis responds with hypertrophy. The stratum cor-
neum thickenes, epidermis becomes acanthotic, and
there is progressive dysplasia with cellular atypia, and
anaplasia. Keratinocytes are irregular with a loss of po-
larity. Melanocytes are irregular with pockets of increa-
sed and decreased numbers. The Langerhans cell popula-
tion in the epidermis is reduced and that contributed to
an impaired immune response to antigen and skin cancer
cells4,5. The roughness of photoaged skin is result of com-
bination of changes in stratum corneum and changes in
the glycosaminoglycan content of the dermis. With age
there is a decrease in glycosaminoglycans in the dermis.
In photoaged skin there is paradoxical increase in gly-
cosaminoglycans when compared with intrinsically aged
skin. But, there are deposited on the abnormal elastotic
material rather than in the papillary dermis and that lo-
cation may make them unavailable as a source of hy-
dratation6. Chronic sun-exposed skin display thickened
basement membrane. Dermal changes are reduction in
collagen and precursors of types I and III collagen, a de-
generation of elastic fibres, which are replaced in time by
an amorphous mass and chronic inflammation with an
increase in degranulated mast cells, macrophages, and
lymphocytes. Blood vessels are dilated and tortuous4. In
addition, because of the diminution of the collagen fra-
mework, the blood vessels are poorly supported; they can
easy rupture, resulting in solar purpura.
For a photochemical reaction to occur in the skin, ul-
traviolet radiation from the sun must be absorbed by
chromophore, beginning a series of photochemic reac-
tions. These chromophores are DNA, aromatic amino ac-
ids, 7-dehydrocholesterol, cytochromes, melanin and bili-
rubin7,8. These reactions can result in changes DNA,
including oxidation of nucleic acids and modify proteins
and lipids, resulting in changes in function. Their accu-
mulation may result in skin cancer or photoaging chan-
ges9. DNA may absorb UVB, directly inducing changes
between adjacent pyrimidine bases on one strand of
DNA, although UVA can also generate thymine dime-
rs10,11. DNA changes are constantly being repaired by nu-
cleotide excision repair. Whenever repair is incomplete
and damage to the genome is great, photodamage may
result5.
Reactive oxygen species are an inherent part of the
anabolism and catabolism of skin. When oxidative stress
is increased, including high metabolic demands and out-
side forces such as sunlight, smoking, and pollution,
protective controls may not be adequate and oxidative
damage may occur. The most damage occurs from free
radicals which are molecules or atoms with an unpaired
electron. These molecules are extremely chemically reac-
tive and short-lived. They react at the place where they
are created and called reactive oxygen species – ROS5.
Reactive oxygen species include superoxide anion, perox-
ide, and singlet oxygen. They can modify proteins in tis-
sue to form carbonyl derivates, which are, accumulate in
the papillary dermis of photodamaged skin12.
Small amount of UV radiation result in the induction
of series of matrix metalloproteinase (MMP) including
MMP-1, MMP-2, MMP-3, and MMP-9. These proteases
are capable of degrading the collagen framework of skin.
At the same time procollagen synthesis is inhibited, per-
haps by a mechanism related to degraded collagen13. Se-
ries of mitogen-activated protein kinases activated in-
duction of transcription factor activation protein (AP-1).
Levels of procollagen I protein are decreased, whereas
MMP-1 and MMP-2 activity are increased. In addition,
the transcription factor, nuclear factor-kB (NF-kB), is ac-
tivated by UV radiation, which stimulates neutrophil at-
traction bringing neutrophil collagenase (MMP-8) into
the irradiation site to future aggravate matrix degrada-
tion. Both AP-1 and NF-kB are activated by ROS. Oxida-
tive stress can also increase elastin messenger RNA lev-
els in dermal fibroblasts providing a mechanism for the
elastotic changes found in photoaged dermis14. UVA can
induce lipid peroxidation in membranes that can lead to
altered membrane fluidity. The DNA in mitochondria
can also be altered by oxidative stress5.
During the evolution the human organisms create dif-
ferent protective adaptation mechanisms to cope with
the adverse effects on solar UV irradiation.
At tissue level, the tanning-response is probably the
most beloved effect of UV rays. Augmented pigmenta-
tion, due to the increased melanin release and synthesis
by melanocytes following UV irradiation, eventuate in
increased protection by formation of an UV absorbing
cap around the nucleus of keratinocytes15,16. UVB and
UVA exposure increases mainly epidermal but also der-
mal mitotic activity. Increased proliferation, and also dif-
ferentiation, increases the thickness of the epidermis, re-
sulting in an extension of the light path. Consequently,
there is a decreased transmission of UV radiation to the
vulnerable cells of the basal and suprabasal layers17.
The keratinocytes themselves have a few protection
mechanisms at their disposal. UV-induced DNA-damage
will specifically be removed by nucleotide excision repair.
Here we can distinguish a very fast transcription coupled
repair and a slower global genomic repair mechanism.
Although the main protein players of these repair sys-
tems differ, the lesions will be removed via the same dif-
ferential steps in both mechanisms. After recognition of
the lesion, in global genoimic nucleotide excision repair
by the xeroderma pigmentosum group C protein and in
transcription coupled nucleotide excision repair by block-
age of RNA polymerase, nucleotide excision repair pro-
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teins are recruited and a multiprotein complex will be
formed15,18. Then, the sequential action of helicases and
endonucleases lead to the removal of the DNA segment
containing the lesion and DNA polymerases fill the re-
maining gap. When damage is totally beyond repair, cells
will go into apoptosis or programmed cell death to get rid
of cells with unrepaired DNA-damage that may give rise
to cancer19,20.
Recent findings suggest a role for interleukin-12
(IL-12) in the response of skin cells to UV rays since addi-
tion of IL-12 to skin cells or skin results in a reduction of
apoptosis or sunburn cell formation. IL-12 was also
found to reduce cyclobutane pyrimidine dimers via in-
duction of nucleotide excision repair21. Since UV-induced
DNA-damage is an important trigger for UV-induced
immunosuppression, the removal of DNA-damage via
IL-12 may clarify its immunostimulatory effect21,22.
The precise molecular mechanisms of a cell that regu-
lates survival (via growth arrest and repair) and the
switch to apoptosis, from a certain level of damage, is not
unraveled yet.
Photoprotection
Sun avoidance is obviously the most efficient way of
photoprotection, however not always practical and some-
times not possible.
Sunscreens
Sunscreens are commonly used as protection against
sun damage, in the form of topical preparations that re-
duce the penetration of damaging solar UV wavelengths
in skin by reflecting or absorbing them. When sunscreen
is applied on the skin, special molecules called UV filters,
cut down the amount of UV radiation that can penetrate
the skin. These filters penetrate into the skin below the
surface of the epidermis, the outermost layer of skin,
leaving the body vulnerable to UV radiation.
Sunscreens are generally qualified with a sun protec-
tion factor (SPF), defined as the minimal erythema dose
(MED) of protected skin divided by the MED of unpro-
tected skin23. Sunscreens reduced acute effects of UV
rays like erythema solare or sunburn. Recent studies
show that regular use of sunscreens can also protect
against the chronic UV effects, as it reduces the carcino-
genic risk24, provides protection against immune suppre-
ssion25 and prevents photoaging26.
Sunscreens are very valuable and should be part of
the first line defense against UV, although they have
their limitations. They have to be used properly to gain
the full effect (application a little while before UV expo-
sure, at frequent time points and in adequate amounts).
Sunscreens have to cope with the problem of photo-
inactivation, which is the degeneration of the UV-filter
due to exposure to UV rays resulting in the loss of ab-
sorbing capacity27–29. Reactive intermediates of photoun-
stable filter substances may come into direct contact
with the skin, where they may behave as photooxidants
or may also promote phototoxic or photoallergic contact
dermatitis29. Photostability of a sunscreen depends on
the filter used, but also on the presence of other UV-fil-
ters or the solvent.
DNA repair enzymes
Importance of adequate DNA repair of especially cy-
clobutane pyrimidine dimers (CPD) lesions considering
the cancer prone nature of cells with disrupted DNA30.
T4 endonuclease V is a bacterial DNA repair enzyme
which specifically recognizes CPD lesions in DNA and
initiates excision repair by cleaving CPD. Subsequently,
host cell enzymes remove the hanging lesion by exonu-
clease activity and refill the remaining gap using the op-
posite strand as a template. T4 endonoclease V, use as
topical treatment in a liposome crème, increases the rate of
repair of sunlight induced DNA-damage and reduced the inci-
dence of pre-malignant actinic keratosis and basal cell carci-
noma Treatment of patients with xeroderma pigmentosum with
T4 endonuclease V lowered the rate of development of skin
cancer31,32.
T4 endonuclease V is a bacterial DNA excision repair
enzyme that repairs cyclobutane pyrimidine dimers in
DNA. As a topical treatment, it removes cyclobutane py-
rimidine dimers in DNA in the epidermis of animals and
human beings33. Topical application of T4 endonuclease
V for 1 year decreased the rate of development of actinic
keratoses and basal cell carcinomas15,33.
Photolyase, a DNA repair enzyme, decreased UVB-in-
duced DNA damage cyclobutane pyrimidine dimers for-
mation by 40% to 45% in human skin when applied im-
mediately after UVB exposure33, resulting in prevention
of immunosuppression, erythema and sunburn forma-
tion15.
DNA repair performed by photolyases occurs via a
mechanism known as 'photoreactivation' pointing to acti-
vation of the enzyme after capture of blue light (300–500
nm) photons. Photoreactivation results in partial repair
of cyclobutane pyrimidine dimers and an increased resis-
tance to UV irradiation. Photoreactivation might be ex-
pected to prevent sunburn and the appearance of skin
cancer. Topical application of photolyase encapsulated
into liposomes decreased the number of UV-induced thy-
midine dimers15.
Antioxidants
Antioxidants are molecules that reduce ROS in the
skin, which are generated by UV damage and lead to
breakdown of collagen. The predominant antioxidants in
skin are vitamin C and E. They neutralize reactive oxy-
gen species before these can produce oxidative stress. Al-
though the amount of vitamins, originating from nutri-
tion, delivered to skin is limited, it appears to be possible
to achieve a higher level of photoprotection by using topi-
cal vitamins34. Antioxidants have been administered ora-
lly and topically for photoprotection in combination with
sunscreens to enhance efficacy. Tocopherol (vitamin E)
and ascorbate (vitamin C) reduce erythema, and sun-
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burn cell formation. Vitamin E also reduces chronic
UVB-induced photodamage and photocarcinogenesis35.
Their no correlation was found between epidermal con-
tent of vitamin E and MED, repeated ingestion of a com-
bination of tocopherol and ascorbate increased the thre-
shold for erythema induction significantly36. Topical
vitamin C has shown to protect the skin from UV damage
caused by prolonged sun exposure by reducing the
amount of free radical formation and/or sunburn cells.
Exposure to UV light has also shown to decrease the nat-
urally occurring vitamin C levels in the skin, thus topical
application of vitamin C restores these photoprotectant
levels. Other studies also suggest that vitamin C may
play a part in the collagen biosynthetic pathway by acti-
vating collagen metabolism and dermal synthesis of elas-
tic fibres35. Topical vitamin C 5% cream applied for six
months led to clinical improvement in the appearance of
photoaged skin with regard to firmness, smoothness, and
dryness compared to vehicle37. Topical vitamin C stimu-
lates the collagen-producing activity of the dermis38.
Polyphenols
Polyphenols, such as flavonoids, are efficient antioxi-
dants due to the presence of hydroxyl groups. However,
those hydroxyl groups bring about a pronounced first
pass effect with a low bioavailability of free flavonoids as
a consequence39. According to recent data, the absorp-
tion of flavonoids might be better then originally belie-
ved36,40.
Green tea polyphenols exhibit anti-inflammatory ac-
tivity, causing inhibition of UV-induced skin erythema,
edema, and a decrease in the number of sunburn cells41.
Epigallocathechin-3-gallate (EGCG) is the main poly-
phenol in green tea and was found to induce differential
effects between tumor cells and normal cells. EGCG was
reported to induce differentiation and proliferation in
epidermal keratinocytes42. Topical application and oral
administration resulted in a strong inhibition of the sun-
burn response and a reduction in sunburn cell forma-
tion43. EGCG inhibits UVB induced erythema, edema,
depletion of the antioxidant enzyme system, IL-10 and
IL-12 production and skin carcinogenesis41. Effects on
photocarcinogenesis include a decrease in tumor burden,
inhibition on the formation and size of malignant and
non-malignant tumors and tumor regression in mice
with established tumors. Effects of green tea polyphenols
in photoaging include the inhibition of UVB induced ex-
pression of matrix metalloproteinases and reduction of
UVB-induced collagen cross-linking33.
Genistein is a soybean isoflavone with a wide range of
antioxidant and anticarcinogenic effects in skin. It is a
potent antioxidant and phytoestrogen presented also in
ginko biloba extact, oregano, and sage41. Clinical studies
indicate that genistein has antiphotocarcinogenic and
antiphotoaging effects for both UVA and UVB. Genistein
blocks UVB-induced sunburns in humans as well as
psoralen-UVA (PUVA) induced molecular damage in
mice. In addition, when applied after UVB exposure,
genistein provides significant comfort and slightly redu-
ces erythema or sunburn44. Genistein also had a powerful
potential to reduce the inflammatory edema reaction and
suppressed contact hypersensitivity induced by moder-
ate doses of solar stimulated UV radiation45. Recent
study has demonstrated that genistein potently mini-
mizes the detrimental effects of UVB irradiation in hu-
man skin by preserving cutaneous proliferation and re-
pair mechanics, inhibition of oxidative and photodynamic
damage to DNA41.
Results indicate that flavonoids are promising candi-
dates for cancer prevention, and in that matter they
might be successful photoprotectants39.
The plant extract Polypodium leucotomos (PL) in-
creases the UV dose required for immediate pigment
darkening, minimal erythema dose, minimal melano-
genic dose and minimal phototoxic dose and down-regu-
lates psoralen-UVA-induced phototoxicity and pigmen-
tary and histological changes33. In a study involving 26
patients with polymorphous light eruption and two pa-
tients with solar urticaria, oral PL has been reported to
improve photosensitivity46.
The mechanism of action of extract Polypodium leuco-
tomos (PLE) is fairly complex. PLE acts as a scavenger to
mop up free radicals and reactive oxygen species (ROS),
particularly superoxide anions. PLE inhibits the deple-
tion of Langerhans cells and reduces the number of sun-
burn cells. PLE protects DNA by inhibiting the forma-
tion of cyclobutane pyrimidine dimers induced by UVB
radiation. PLE preserves skin tissue structure by inhibit-
ing the infiltration of mast cells into skin wicth leads to
inhibition redness, inflammation and itching.
It should be considered as another layer of protection
and used in conjunction with a good sunscreen and pro-
tective clothing.
PLE can also be used as a chemophotoprotector against
PUVA-induced skin phototoxicity. Extensive PUVA treat-
ment results in premature aging changes in the skin and
can increase the chance of skin cancer. Fair skinned indi-
viduals or those with previous sun or radiation damage
are most at risk. In clinical trials, PLE has proven to be
the first oral agent effective in reducing the harmful side
effects of PUVA treatment47.
Polypodium leucotomos blocked the deleterious effect
of UV irradiation both in vivo and in vitro. The molecular
basis of photoprotection relies on its ability to inhibit
free radical generation, prevent photodecomposition of
both endogenous photoprotective molecules and DNA,
and prevent UV-induced cell death. Its complete loss of
toxicity combined with its multifactor protection makes
it a valuable tool not only for direct photoprotection, but
also as an efficacious adjuvant to phototherapy of various
skin diseases48.
Conclusion
In the past, carcinogenesis of the skin was mainly at-
tributed to UVB radiation and the most sun-protection
measures were geared toward blocking UVB rays. The
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recently research has revealed the importance of UVA
exposure in skin cancer and premature photoaging2.
UVA is just as dangerous as UVB, and new developments
are focused on UVA protection, immune protection, and
public awareness49. The main topic of this review is to
mention new or alternative ways of photoprotection.
UV exposure causes immunosuppression via multiple
mechanisms in the skin including via urocanic acid. Any
exposure to the sun disables the immune system’s ability
to fight skin cancer. The DNA mutations formed during
childhood tanning or burning may cause skin cancers in
adulthood, especially with more and more sun exposure.
Products with immune protection factor contain DNA-
-repair enzymes and antioxidants that may reduce muta-
tions and enable the immune system to combat pho-
todamage. Topical treatment with repair enzymes may
be a promising avenue for after sun protection of UV-ir-
radiated skin. If topical immune protection factors prove
to be safe but only moderately effective, systemic medica-
tions targeted at immunomodulation of the skin and im-
munity-driven technology will be a future direction in
skin cancer prevention and treatment.
The use of antioxidants both orally and topically, as
preliminary studies demonstrate may exert an anti-aging
effect by preventing and even reversing sun damage.
Adequate photprotection is essential to control pho-
tocarcinogenesis and photoaging.
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NOVE MOGU^NOSTI FOTOPROTEKCIJE
S A @ E T A K
Svi ljudi su izlo`eni sun~evom ultravioletnom zra~enju. Izlaganje suncu, uz `ivot u atmosferi bogatom kisikom,
dovodi do ne`eljenih o{te}enja ko`e. Izrazito osun~ana ko`a je vode}i faktor rizika za nastanak malginog melanoma i
ostalih tumora ko`e. Ultravioletno zra~enje, razli~itim mehanizmima, uzrokuje imunosupresiju u ko`i. U ovom pre-
glednom radu `eljeli smo upozoriti na nove i alternativne mogu}nosti za{tite od sunca. Sredstva za za{titu od sunca
koriste se za prevenciju i smanjenje o{te}enja uslijed izlaganja ultravioletnim zrakama. Ona smanjuju prodiranje ultra-
violetnih zraka u ko`u tako da ih reflektiraju i apsorbiraju. Korisna su, ali imaju ograni~enja. Moraju se koristiti na
pravilan na~in da bi polu~ili efekt (aplikacija neposredno pred izlaganje suncu, u~estala aplikacija u dovoljnoj koli~ini).
Tako|er, dolazi do inaktivacije ultravioletnih filtera tijekom izlaganja ultravioletnim zrakama i gubitka sposobnosti
apsorpcije. Proizvodi koji sadr`e imunolo{ki za{titni faktor sadr`e DNK repariraju}e enzime i antioksidanse. Sposobni
su smanjiti mutacije te pove}avaju sposobnosti imunolo{kog sistema u obrani od foto-o{te}enja ko`e. Upotreba anti-
oksidansa i polifenola mo`e prevenirati i smanjivati o{te}enja uslijed izlaganja ultravioletnim zrakama te unaprijediti
za{titu od starenje pod utjecajem sunca. Pravilna za{tita od sunca neophodna je u kontroli foto-karcionogeneze i foto-
-starenja.
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